These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 36774402)

  • 1. DeepInsight-3D architecture for anti-cancer drug response prediction with deep-learning on multi-omics.
    Sharma A; Lysenko A; Boroevich KA; Tsunoda T
    Sci Rep; 2023 Feb; 13(1):2483. PubMed ID: 36774402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Local augmented graph neural network for multi-omics cancer prognosis prediction and analysis.
    Zhang Y; Xiong S; Wang Z; Liu Y; Luo H; Li B; Zou Q
    Methods; 2023 May; 213():1-9. PubMed ID: 36933628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNNGP, a deep neural network-based method for genomic prediction using multi-omics data in plants.
    Wang K; Abid MA; Rasheed A; Crossa J; Hearne S; Li H
    Mol Plant; 2023 Jan; 16(1):279-293. PubMed ID: 36366781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DeepFeature: feature selection in nonimage data using convolutional neural network.
    Sharma A; Lysenko A; Boroevich KA; Vans E; Tsunoda T
    Brief Bioinform; 2021 Nov; 22(6):. PubMed ID: 34368836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MOLI: multi-omics late integration with deep neural networks for drug response prediction.
    Sharifi-Noghabi H; Zolotareva O; Collins CC; Ester M
    Bioinformatics; 2019 Jul; 35(14):i501-i509. PubMed ID: 31510700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How much can deep learning improve prediction of the responses to drugs in cancer cell lines?
    Chen Y; Zhang L
    Brief Bioinform; 2022 Jan; 23(1):. PubMed ID: 34529029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DeepDRK: a deep learning framework for drug repurposing through kernel-based multi-omics integration.
    Wang Y; Yang Y; Chen S; Wang J
    Brief Bioinform; 2021 Sep; 22(5):. PubMed ID: 33822890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A deep neural network approach to predicting clinical outcomes of neuroblastoma patients.
    Tranchevent LC; Azuaje F; Rajapakse JC
    BMC Med Genomics; 2019 Dec; 12(Suppl 8):178. PubMed ID: 31856829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GraphCDR: a graph neural network method with contrastive learning for cancer drug response prediction.
    Liu X; Song C; Huang F; Fu H; Xiao W; Zhang W
    Brief Bioinform; 2022 Jan; 23(1):. PubMed ID: 34727569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MODILM: towards better complex diseases classification using a novel multi-omics data integration learning model.
    Zhong Y; Peng Y; Lin Y; Chen D; Zhang H; Zheng W; Chen Y; Wu C
    BMC Med Inform Decis Mak; 2023 May; 23(1):82. PubMed ID: 37147619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deep learning and multi-omics approach to predict drug responses in cancer.
    Wang C; Lye X; Kaalia R; Kumar P; Rajapakse JC
    BMC Bioinformatics; 2022 Nov; 22(Suppl 10):632. PubMed ID: 36443676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene-centric multi-omics integration with convolutional encoders for cancer drug response prediction.
    Lee M; Kim PJ; Joe H; Kim HG
    Comput Biol Med; 2022 Dec; 151(Pt A):106192. PubMed ID: 36327883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. moBRCA-net: a breast cancer subtype classification framework based on multi-omics attention neural networks.
    Choi JM; Chae H
    BMC Bioinformatics; 2023 Apr; 24(1):169. PubMed ID: 37101124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic Drug Combination Prediction by Integrating Multiomics Data in Deep Learning Models.
    Zhang T; Zhang L; Payne PRO; Li F
    Methods Mol Biol; 2021; 2194():223-238. PubMed ID: 32926369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multi-omics integration method based on attention deep learning network for biomedical data classification.
    Gong P; Cheng L; Zhang Z; Meng A; Li E; Chen J; Zhang L
    Comput Methods Programs Biomed; 2023 Apr; 231():107377. PubMed ID: 36739624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A fair experimental comparison of neural network architectures for latent representations of multi-omics for drug response prediction.
    Hauptmann T; Kramer S
    BMC Bioinformatics; 2023 Feb; 24(1):45. PubMed ID: 36788531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrating multi-omics data by learning modality invariant representations for improved prediction of overall survival of cancer.
    Tong L; Wu H; Wang MD
    Methods; 2021 May; 189():74-85. PubMed ID: 32763377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MABAL: a Novel Deep-Learning Architecture for Machine-Assisted Bone Age Labeling.
    Mutasa S; Chang PD; Ruzal-Shapiro C; Ayyala R
    J Digit Imaging; 2018 Aug; 31(4):513-519. PubMed ID: 29404850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CustOmics: A versatile deep-learning based strategy for multi-omics integration.
    Benkirane H; Pradat Y; Michiels S; Cournède PH
    PLoS Comput Biol; 2023 Mar; 19(3):e1010921. PubMed ID: 36877736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Explaining decisions of graph convolutional neural networks: patient-specific molecular subnetworks responsible for metastasis prediction in breast cancer.
    Chereda H; Bleckmann A; Menck K; Perera-Bel J; Stegmaier P; Auer F; Kramer F; Leha A; Beißbarth T
    Genome Med; 2021 Mar; 13(1):42. PubMed ID: 33706810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.